Presentation TCT 2020 TCT 380: 2-Years Results of the Novel Sirolimus Eluting Stent in an All-comer High-risk Population Presenter: Luca Testa October 14, 2020
Presentation TCT 2020 TCT 382: Feasibility and Safety of High-Risk Percutaneous Coronary Intervention Without Mechanical Circulatory Support Presenter: Nausharwan Butt October 14, 2020
Presentation TCT 2020 TCT 287: Treatment of Patients With Recurrent In-Stent Restenosis Who Failed Intravascular Brachytherapy Presenter: Charan Yerasi October 14, 2020
Presentation TCT 2020 TCT 290: Evaluating the Long-term Clinical Outcomes of Different Treatment Modalities for Intra-stent Chronic Total Occlusion Presenter: Sandeep Basavarajaiah October 14, 2020
Presentation TCT 2020 TCT 286: Long-Term Outcomes Following Drug-Eluting Balloon Versus Thin-Strut Drug-Eluting Stents for Treatment of In-Stent Restenosis: Multicenter Propensity Score-Matched Analysis (DEB-Dragon Registry) Presenter: Wojciech Wanha October 14, 2020
Presentation TCT 2020 TCT 271: The MeRes-1 Extend Trial: Two-Year Clinical and Six-Month Imaging Outcomes of Thin Strut Sirolimus-Eluting BRS in Patients With De Novo Coronary Artery Lesions Presenter: Alexandre Abizaid October 14, 2020
Presentation TCT 2020 TCT 252: Use of Sirolimus-Coated Balloon in De Novo Small Vessel Coronary Lesions; Long-Term Follow-Up From a Single Centre Registry Presenter: A D S P K Athukorala October 14, 2020
Presentation TCT 2020 TCT 249: Real-world Dual Antiplatelet Therapy Following Polymer-free, Sirolimus-Eluting Stent Implantations to Treat Coronary Artery Disease Presenter: Markus Krackhardt October 14, 2020
Presentation TCT 2020 TCT 262: Percutaneous Coronary Intervention of Long Coronary Lesions With the Bioabsorbable Polymer-Coated, Everolimus-Eluting SYNERGY 48 mm Stent: Primary Outcomes of the EVOLVE 48 Study Presenter: Dimitri Karmpaliotis October 14, 2020
Presentation TCT 2020 TCT 268: Safety and Performance of the Resorbable Magnesium Scaffold, Magmaris in a Real World Setting – NSTEMI, Diabetes and B2/C Lesion Subgroups Analyses of the First Cohort Subjects at 12-month Follow-up of the BIOSOLVE-IV Registry Presenter: Adrian Wlodarczak October 14, 2020